CRVS vs RHI · $1.04B cap vs P/E 21, rev $5.38B
Corvus Pharmaceuticals Inc (CRVS) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
CRVS does not have a complete income-statement cache yet.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
CRVS currently screens at market cap $1.04B. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the CRVS and RHI stock pages for the full models.
Not investment advice.